Publicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (12)

2023

  1. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma

    Cancers, Vol. 15, Núm. 5

2021

  1. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients

    British Journal of Haematology, Vol. 189, Núm. 4, pp. 718-730

2018

  1. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study

    Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484

2016

  1. Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy

    British Journal of Haematology, Vol. 174, Núm. 6, pp. 859-867

2015

  1. Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León

    Medicina Clinica, Vol. 144, Núm. 11, pp. 491-500

2009

  1. Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion

    Leukemia Research

2006

  1. Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages

    Journal of Thrombosis and Thrombolysis, Vol. 22, Núm. 2, pp. 113-120

2004

  1. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction

    Circulation Research, Vol. 95, Núm. 7, pp. 742-748

2003

  1. Emphysematous gastritis and severe aplastic anemia

    Hematology Journal, Vol. 4, Núm. 1, pp. 82-84

  2. Tratamiento de la coagulopatía en la sepsis severa

    Revista Clinica Espanola, Vol. 203, Núm. 5, pp. 240-241

2002

  1. Leucemia linfática crónica, fiebre y adenopatía inguinal

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 2, pp. 136-140